1952
DOI: 10.1016/0021-8707(52)90022-1
|View full text |Cite
|
Sign up to set email alerts
|

The inhalation test as a diagnostic procedure with special emphasis on the house dust allergen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1956
1956
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(9 citation statements)
references
References 7 publications
0
9
0
Order By: Relevance
“…The FEV 1 was named and its technology standardized in 1957 (32). Initial use of expiratory flow rates to measure the EAR included the somewhat subjective end points of a clearcut reduction in expiratory flows (33) or the French equivalent the dose liminaire required to produce a tangible spirometric change (34). The FEV 1 , now the standard end point for measurement of most bronchoprovocation studies with allergen or others, became established in the late 1950s (35) and thereafter as the end point, generally expressed as a percentage change, used to monitor allergen provocation.…”
Section: Early Asthmatic Responsementioning
confidence: 99%
“…The FEV 1 was named and its technology standardized in 1957 (32). Initial use of expiratory flow rates to measure the EAR included the somewhat subjective end points of a clearcut reduction in expiratory flows (33) or the French equivalent the dose liminaire required to produce a tangible spirometric change (34). The FEV 1 , now the standard end point for measurement of most bronchoprovocation studies with allergen or others, became established in the late 1950s (35) and thereafter as the end point, generally expressed as a percentage change, used to monitor allergen provocation.…”
Section: Early Asthmatic Responsementioning
confidence: 99%
“…Since Curry [1946,1947], Curry and Lowell [1948], H erxheimer [1951 a-c, 1952], H erxheimer and Prior [1952] and Tiffeneau [1955, 1959 a, b], Tiffeneau and Beauvallet [1945], Tiffeneau and Brutel [1955] described the bronchoconstrictor effect of inhaled histamine, acetylcholine, and allergens on the respiratory tract in patients with chronic nonspecific lung diseases (CNSLD), numerous publications have been devoted to this subject [Beumer, 1966;Bouhuys, 1967;Bouhuys et al, 1960;D ukstra, 1963;Citron, 1967;Colldahl, 1967;D ebelic, 1968;D ebelic and Vir chow, 1970;Fréour et al, 1970;G roetenbriel et a l, 1968;G ronemeyer and Fuchs, 1959; K lein and Salvaggio, 1966; Lecomte and Petit, 1960;Maier et al, 1970;Makino, 1966;Marcelli, 1963;Marcelli et al, 1965;N ilsson and Kaude, 1960;Rebohle and Jager, 1968;Segal et al, 1949;Schiller and Lowell, 1952;Stennis, 1970;De Vries et al, 1964, 1968.…”
Section: Introductionmentioning
confidence: 99%
“…He wrote: However, in clinical reality with humans an universal shock mostly does not occur, rather only one or several symptoms of a shock are clearly apparent, which we want to call 'shock fragments'. Richard Otto (1872-1952 fig. 17 ) worked at the Imperial Health Centre in Berlin and documented further important details of anaphylaxis: the incubation time is between 8-10 days, the reaction is specific and stops approximately 2-3 months later, the sensitization can be transferred passively by mothers to their newborns and a large number of antigens (animal, herbal, bacterial) are able to induce anaphylactic reactions, including non-toxic antigens [18] .…”
Section: Anaphylaxis In the Clinical Routinementioning
confidence: 99%
“…A reduction of 10% in vital capacity was considered as evidence of sensitivity. The incidence of skin reactions was much higher than of pulmonary reactions, and there were no pulmonary reactions with allergens which did not result in skin reactions [51] .…”
Section: Inhalation Testsmentioning
confidence: 99%